Polymyalgia rheumatica: An updated review.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32868305.
- Also identified by DOI 10.3949/ccjm.87a.20008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Polymyalgia rheumatica should be suspected in older patients with bilateral shoulder and hip stiffness that is worse in the morning and improves with use. An array of nonspecific musculoskeletal complaints, constitutional symptoms, and elevated serum inflammatory markers may be present, so other conditions should also be considered. Prolonged glucocorticoids with patient-tailored dosing and duration are the mainstay of treatment. Corticosteroid-sparing therapy with adjunctive methotrexate may benefit select patients.
Medical subject headings
- Antirheumatic Agents
- Polymyalgia Rheumatica